UCB-Pharma SA - Neupro 8 mg/24h, dispositif transdermique
57417
12
Neupro 8 mg/24h
dispositif transdermique
N04BC09
Rotigotine
05.03.2014
Composition
rotigotinum 18.00 mg, silicone adhesive, povidonum K 90, E 223, E 304, E 307, poly(ethylenis terephthalas), ad praeparationem pro 40 cm², cum liberatione 8 mg/24h.
